India has indeed launched its first microRNA-based blood test for breast cancer screening. The test, named Cantel™ , was developed by Hyderabad-based Precision RNA Biotech Pvt. Ltd. (also known as Prerna) and announced in mid-October 2025.​ Cantel™ represents a groundbreaking step in India’s cancer diagnostics as the first microRNA (miRNA)-based blood test specifically designed for early breast cancer detection . It identifies unique miRNA signatures in the blood that serve